-->

On:

Mexico City, Mexico – January 10, 2026 – (SeaPRwire) – Excent Capital has announced the launch of a new incentive program for its global partner network, offering exclusive experiences connected to the 2026 World Cu as part of its ongoing commitment to long-term collaboration and partner engagement. The initiative is designed to recognise partner performance and strengthen relationships through experiences that go beyond traditional rewards. Depending on performance tiers, partners may qualify for packages that include match tickets, travel arrangements, accommodation, and curated experiences in the United States during the tournament. Rather than focusing solely on volume, the program is structured to encourage sustainable growth, strategic alignment, and continued collaboration between Excent Capital and its partners. The incentive tiers are linked to clearly defined performance benchmarks, ensuring transparency and consistency across regions. “We work very closely with our partners on a daily basis, and this initiative is a way to give something back that goes beyond numbers,” said Andrés Espinosa, Senior Business Development Manager at Excent Capital. The World Cup 2026 incentive program is open to eligible partners worldwide and will run until May 15. Participation details, performance criteria, and tier qualifications are communicated directly to partners through Excent Capital’s regional business development teams. About Excent Capital Excent Capital is a global trading broker offering access to a wide range of financial markets. Operating on proprietary, in-house developed technology, the company focuses on transparency, execution quality, and partner-driven growth, supporting partners through education, consistent market insight, and collaborative initiatives. Contact Information Organization: Excent Capital Contact Person: Ryccielli Ongaratto, Marketing Manager Email: support@excent.capital Website: https://excent.capital/

On:

London, United Kingdom – January 08, 2026 – (SeaPRwire) – Capital Margin Trade has announced a continued focus on strengthening its trading tools, placing practicality ahead of feature volume. The initiative reflects a broader effort to refine how traders interact with the platform on a daily basis, particularly in environments where clarity, timing, and execution discipline tend to outweigh visual appeal or experimental features. The Capital Margin Trade trading platform is built around a straightforward premise. Trading tools should work together smoothly and remain accessible under real market conditions. Market access, charting, and order management are combined within a single interface, reducing the need to switch between sections during active trading. Over time, this type of structure often proves more valuable than frequent interface changes that require constant readjustment. Charting has been one of the more fully formed components of the platform. With multiple chart time frames, layered indicators, and customizable chart layouts, users have an opportunity to evaluate price action without extraneous distractions. The tools continue to remain stable even in times of increased volatility, which is often when stability can become a major issue. While the platform does not aim to replicate institutional-grade software, it offers sufficient analytical depth to support structured technical analysis and routine market monitoring. Execution tools on the Capital Margin Trade broker platform follow a similar logic. Orders can be placed and managed without interrupting the broader workflow, allowing traders to stay focused on market movement rather than interface navigation. Real-time price feeds across supported instruments provide continuous visibility, helping users react as conditions change. Execution speed, as with any platform, remains dependent on market conditions, though overall performance is generally consistent during standard trading hours. Risk management features are integrated directly into the trading process. Users can input a stop-loss and/or take-profit level at the time they enter a trade, or adjust those levels once their trades are active. This provides users with the opportunity to make decisions based upon their own risk assessment without forcing the use of pre-defined automated strategy templates. While some traders may look for deeper automation, others may value the ability to remain closely involved in managing exposure. Beyond execution and charting, the Capital Margin Trade trading platform includes a market overview section that offers context without constant interruptions. Instead of relying on frequent alerts, traders can access summarized information when needed. This quieter approach supports independent analysis and may suit users who prefer to interpret data rather than respond to prompts. Accessibility across devices remains consistent. The Capital Margin Trade broker infrastructure is web-based, allowing traders to access accounts from desktops, laptops, tablets, or smartphones without additional downloads. While mobile trading naturally limits screen space, essential functions such as monitoring positions and placing orders remain available, which can be useful for traders managing positions away from their primary setups. In terms of the way the user interacts with the platform, there are multiple layers of operational complexity. The account settings, margin controls, and view of all open positions are clearly defined and separate from each other, allowing for greater ease of managing exposure to risk without having to navigate through layers of menu options. During active market phases, this clarity can help reduce operational friction. Traders seeking highly customized algorithmic environments may find the setup more manual, though this appears intentional for users who prefer hands-on control. Funding and withdrawal processes follow established industry standards. The platform supports commonly used payment methods and prioritizes reliability over experimentation. While options may seem limited for users seeking alternative payment solutions, transaction procedures remain clear and supported by standard verification processes. Security is treated as a baseline requirement rather than a headline feature. Capital Margin Trade trading platform operations include user verification protocols and encrypted data handling designed to protect account access and transactional information without adding unnecessary complexity to daily use. Overall, the ongoing development of Capital Margin Trade broker services suggests a measured, methodical approach. The emphasis has shifted from seeking rapid expansion and numerous new features every few weeks to maintaining a consistent and reliable trading environment. The steady, long-term nature of this strategy could be attractive to those who have become accustomed to using a platform that they feel comfortable with over time, as opposed to having to adjust to rapidly changing tool behavior and workflow changes at short notice. In addition, for traders who place high value on stability, consistency, and predictability in their trading activities (i.e., those who are able to derive long-term benefits from the familiarity of a consistent trading environment), this long-term approach will likely lead to a more productive long-term trading experience than one based on continuous upgrades. About Capital Margin Trade Capital Margin Trade is an online brokerage firm that provides web-based access to global financial markets, utilizing a web-based trading platform. Capital Margin Trade is focused on providing useful tools to assist traders, along with a stable, functional platform structure that supports traders who take a disciplined, execution-oriented approach to trading versus traders who want to constantly experiment with feature-rich platforms. Media Contact Brand: Capital Margin Trade Contact: Media Relations Team Email: press@capitalmargintrade.com Website: https://capitalmargintrade.com

-->

On:

ยึดหลักการพัฒนาในระยะยาวเป็นแกนหลัก ก้าวสู่ยุคใหม่ของการเติบโตที่มีคุณภาพและการพัฒนาเชิงภูมิภาค เมื่อไม่นานมานี้ PGM ได้ประกาศต่อสาธารณชนอย่างเป็นทางการถึง กลยุทธ์การพัฒนาปี 2026 และ แผนพัฒนาระยะกลางถึงระยะยาวสำหรับปี 2027–2028 ภายใต้บริบทที่เศรษฐกิจดิจิทัลทั่วโลกยังคงพัฒนาอย่างต่อเนื่อง และโครงสร้างองค์กรมีการยกระดับอยู่ตลอดเวลา PGM จะยึดแนวคิดการพัฒนาโดยมี “ความมั่นคง ความถูกต้องตามกฎหมาย และการมุ่งเน้นระยะยาว” เป็นแกนหลัก เพื่อขับเคลื่อนการยกระดับองค์กร การพัฒนาระบบ และการขยายเชิงภูมิภาคอย่างรอบด้าน วางรากฐานที่แข็งแกร่งสำหรับการเติบโตอย่างต่อเนื่องในอนาคต PGM ระบุว่า แผนการพัฒนาครั้งนี้ไม่ได้มุ่งเน้นการขยายขนาดในระยะสั้น แต่ให้ความสำคัญกับ การพัฒนาอย่างยั่งยืนในระยะยาว โดยมุ่งสร้างแพลตฟอร์มที่มี โครงสร้างชัดเจน การดำเนินงานมีเสถียรภาพ และสามารถนำไปขยายหรือทำซ้ำได้ อย่างเป็นระบบ 1. กลยุทธ์การพัฒนา ปี 2026: วางรากฐานให้มั่นคง ยกระดับคุณภาพ ปี 2026 จะถูกมองว่าเป็น “ปีแห่งการวางรากฐานสำคัญ” ของการพัฒนา PGM โดยบริษัทจะเดินหน้าดำเนินงานอย่างมั่นคงภายใต้ 4 แนวทางเชิงกลยุทธ์หลัก ดังต่อไปนี้: (1) ยกระดับโครงสร้างองค์กร เสริมสร้างศักยภาพด้านการบริหาร PGM จะเดินหน้าปรับปรุงโครงสร้างองค์กรและการแบ่งหน้าที่ความรับผิดชอบอย่างต่อเนื่อง พัฒนาระบบการเลื่อนตำแหน่งและการบ่มเพาะผู้บริหาร โดยมุ่งเน้นการยกระดับความสามารถของผู้บริหารระดับกลางและระดับสูง เพื่อสร้างโครงสร้างทีมงานที่มีเสถียรภาพและยั่งยืนมากยิ่งขึ้น (2) เสริมความแข็งแกร่งด้านการปฏิบัติตามกฎระเบียบและการบริหารความเสี่ยงอย่างรอบด้าน ในด้านการดำเนินงานที่ถูกต้องตามกฎหมาย PGM จะยกระดับความโปร่งใสทางการเงิน ระบบตรวจสอบภายใน และศักยภาพด้านการควบคุมความเสี่ยงของระบบ พร้อมทั้งเสริมสร้างความปลอดภัยของข้อมูลและการบริหารบัญชีอย่างต่อเนื่อง เพื่อยืนยันและตอกย้ำจุดยืนของตลาดในฐานะ “ตำแหน่งงานที่เป็นทางการ การดำเนินงานที่ถูกต้องตามกฎหมาย และการพัฒนาในระยะยาว” (3) ยกระดับระบบและศักยภาพด้านเทคโนโลยี PGM มีแผนดำเนินการอัปเกรดระบบหลายด้านภายในปี 2026 ครอบคลุมถึงการทำงานอัตโนมัติของกระบวนการดำเนินงาน การพัฒนาระบบสถิติข้อมูล และการปรับปรุงการคำนวณผลการปฏิบัติงาน เพื่อสร้างโครงสร้างพื้นฐานทางเทคโนโลยีที่มีเสถียรภาพและประสิทธิภาพ รองรับการขยายตัวในระดับขนาดใหญ่และการพัฒนาข้ามภูมิภาคในอนาคต (4) การสร้างแบรนด์และการสื่อสารเชิงบวกกับตลาด ผ่านการกำหนดแนวทางการสื่อสารภายนอกอย่างเป็นเอกภาพ และการเสริมสร้างการสื่อสารผ่านสื่อหลักและแพลตฟอร์มโซเชียลมีเดีย PGM จะยกระดับความน่าเชื่อถือของแบรนด์อย่างต่อเนื่อง และสร้างภาพลักษณ์องค์กรในฐานะ “องค์กรที่มั่นคง เป็นมืออาชีพ และเชื่อถือได้” 2. แผนพัฒนาระยะกลางถึงระยะยาว ปี 2027–2028: เจาะลึกตลาดเอเชียตะวันออกเฉียงใต้ เดินหน้าการขยายขนาดและการพัฒนาเชิงภูมิภาคควบคู่กัน หลังจากการวางรากฐานระบบต่าง ๆ เสร็จสมบูรณ์ในปี 2026 แล้ว PGM จะก้าวเข้าสู่ช่วงเร่งการพัฒนา เชิงขนาดและเชิงภูมิภาคโดยมีเอเชียตะวันออกเฉียงใต้เป็นศูนย์กลาง อย่างเป็นทางการในช่วงปี 2027–2028 บริษัทจะมุ่งเน้นการขยายตลาดในภูมิภาคเอเชียตะวันออกเฉียงใต้ โดยเฉพาะ ประเทศไทยและเมียนมา และดำเนินการขยายพื้นที่อย่างมั่นคงบนพื้นฐานของโมเดลการดำเนินงานที่มีความพร้อมและผ่านการพิสูจน์แล้ว ปี 2027: การพัฒนาเชิงขนาดอย่างมั่นคง ขยายขนาดทีมงานอย่างต่อเนื่องในตลาดที่มีความพร้อม พัฒนาผู้นำท้องถิ่นที่มีศักยภาพในการบริหารจัดการอย่างอิสระและสามารถถ่ายทอดรูปแบบการดำเนินงานได้ ยกระดับประสิทธิภาพการดำเนินงานโดยรวม ประสิทธิภาพต่อบุคลากร และความมั่นคงของทีมงาน ปี 2028: ผลักดันการพัฒนาเชิงภูมิภาคและการทำงานร่วมกัน ค่อย ๆ ดำเนินการขยายรูปแบบการดำเนินงานไปยังภูมิภาคอื่นบนพื้นฐานของโมเดลที่มีความพร้อม สร้างระบบการบริหารจัดการและการทำงานร่วมกันข้ามภูมิภาค พัฒนาระบบการดำเนินงานหลายภูมิภาคที่มีความยั่งยืนในระยะยาว PGM ระบุว่า การพัฒนาเชิงภูมิภาคจะยึดหลัก “ค่อยเป็นค่อยไป และควบคุมความเสี่ยงได้” เป็นเงื่อนไขสำคัญ เพื่อให้มั่นใจว่าทุกขั้นตอนของการขยายตัวจะตั้งอยู่บนระบบที่มีความสมบูรณ์และมีเสถียรภาพ 3. การขับเคลื่อนการพัฒนาเชิงท้องถิ่นในประเทศไทย: เร่งจัดตั้งระบบความร่วมมือด้านโฆษณา จากการที่ความร่วมมือกับ แบรนด์ท้องถิ่นในประเทศไทยเพิ่มขึ้นอย่างต่อเนื่อง ความต้องการด้านการประสานงานโฆษณาและความร่วมมือทางธุรกิจของแพลตฟอร์มจึงมีความชัดเจนมากยิ่งขึ้น ภายใต้แนวโน้มดังกล่าว PGM กำลังดำเนินการตามแผนอย่างเป็นขั้นตอน เพื่อจัดตั้ง ฝ่ายพัฒนาธุรกิจและความร่วมมือด้านโฆษณา ของบริษัทสาขาในประเทศไทย โดยให้ความสำคัญกับการวางแผนระยะเริ่มต้นใน อาคารสำนักงานย่านธุรกิจของกรุงเทพมหานคร ปัจจุบัน แผนงานที่เกี่ยวข้องได้เข้าสู่ ขั้นตอนการเตรียมการ ซึ่งครอบคลุมถึง การวางแผนสภาพแวดล้อมและพื้นที่สำนักงาน การประเมินโครงสร้างและการจัดสรรบุคลากร การปรับปรุงและเชื่อมต่อกระบวนการดำเนินงานด้านโฆษณาให้สอดคล้องกับระบบแพลตฟอร์ม หากการดำเนินงานโดยรวมเป็นไปอย่างราบรื่น คาดว่าจะสามารถ เริ่มเข้าพื้นที่และเปิดดำเนินงานในระยะแรกได้ภายในระยะเวลาประมาณหนึ่งเดือน เพื่อยกระดับประสิทธิภาพในการเชื่อมต่อกับแบรนด์ท้องถิ่นและทรัพยากรความร่วมมือทางธุรกิจในประเทศไทย บริษัทจะดำเนินการพัฒนาและปรับปรุงแผนงานในระยะถัดไปอย่างมั่นคงตามสถานการณ์จริง พร้อมทั้งเตรียมความพร้อมล่วงหน้าสำหรับ การจัดตั้งและการเข้าใช้อาคารสำนักงานอิสระของ PGM ประเทศไทยในอนาคต PGM ยังคงยึดมั่นในหลักการพัฒนา “วางแผนก่อนดำเนินการจริง ให้ความสำคัญกับระยะยาว และเน้นความมั่นคง” เพื่อให้ทุกขั้นตอนของการขยายตัวมีคุณค่าและความยั่งยืนในระยะยาว 4. แนวคิดการพัฒนาในระยะยาวโดยยึด “บุคลากร” เป็นศูนย์กลาง PGM ยึดมั่นมาโดยตลอดว่า การเติบโตในระยะยาวของพนักงาน คือขีดความสามารถในการแข่งขันที่สำคัญที่สุดขององค์กร ในช่วง สามปีข้างหน้า บริษัทจะเดินหน้าลงทุนทรัพยากรอย่างต่อเนื่องในด้าน การพัฒนาบุคลากรและผู้บริหาร การสร้างระบบแรงจูงใจในระยะยาว การออกแบบโครงสร้างรายได้ที่หลากหลายและยั่งยืน เพื่อมอบเส้นทางการพัฒนาอาชีพที่ ชัดเจน มีเสถียรภาพ และสามารถคาดการณ์ได้ ให้แก่พนักงานทุกคน พร้อมส่งเสริมให้เกิดวงจรการเติบโตเชิงบวกระหว่างการพัฒนาของบุคลากรและการเติบโตของแพลตฟอร์ม 5. การปฏิบัติความรับผิดชอบต่อสังคม: ตอบแทนสังคมด้วยกิจกรรมสาธารณประโยชน์ในระยะยาว ควบคู่ไปกับการขับเคลื่อนการพัฒนาองค์กรอย่างมั่นคง PGM ให้ความสำคัญกับการลงทุนด้านความรับผิดชอบต่อสังคมขององค์กรในระยะยาวมาโดยตลอด ในช่วง สามปีข้างหน้า PGM จะบูรณาการกิจกรรมด้านสาธารณประโยชน์และการกุศลเข้าเป็นส่วนหนึ่งของระบบการพัฒนาองค์กรในระยะยาว เพื่อคืนกลับสู่สังคมผ่านแนวทางที่ ต่อเนื่อง เป็นรูปธรรม และสามารถดำเนินการได้จริง เมื่อเดือนที่ผ่านมา PGM ได้ตอบสนองต่อสถานการณ์อุทกภัยในพื้นที่จังหวัดสงขลาอย่างเร่งด่วน โดยจัดทีมงานลงพื้นที่ประสบภัยเพื่อให้ความช่วยเหลือแก่ประชาชนที่ได้รับผลกระทบ ทิศทางหลักของกิจกรรมสาธารณประโยชน์ การดูแลชุมชน: ดำเนินกิจกรรมช่วยเหลือชุมชนระดับฐานรากอย่างสม่ำเสมอ พร้อมการมอบสิ่งของอุปโภคบริโภคที่จำเป็น การสนับสนุนด้านการศึกษา: ให้ความสำคัญกับโอกาสทางการศึกษาและสภาพแวดล้อมในการเติบโตของเยาวชนและกลุ่มผู้ด้อยโอกาส การมีส่วนร่วมของพนักงาน: ส่งเสริมให้พนักงานและทีมงานเข้าร่วมกิจกรรมสาธารณประโยชน์ร่วมกัน เพื่อสร้างวัฒนธรรมองค์กรเชิงบวก PGM เชื่อมั่นว่า องค์กรที่ยั่งยืนอย่างแท้จริง ไม่เพียงสร้างคุณค่าทางเศรษฐกิจเท่านั้น แต่ยังต้องสร้างคุณค่าทางสังคมอย่างต่อเนื่องควบคู่กันไป PGM ดำเนินกิจกรรมเพื่อสังคมในระดับชุมชนอย่างต่อเนื่อง และปฏิบัติความรับผิดชอบต่อสังคมขององค์กรอย่างจริงจัง โดยให้ความสำคัญกับการพัฒนาด้านการศึกษา และสนับสนุนการเติบโตของเยาวชนผ่านการลงมือปฏิบัติจริง การมีส่วนร่วมของพนักงานในกิจกรรมสาธารณประโยชน์ได้กลายเป็นส่วนสำคัญของวัฒนธรรมองค์กรของ PGM สำหรับ PGM กิจกรรมสาธารณประโยชน์ไม่ใช่การดำเนินการเพียงครั้งเดียว แต่เป็นแนวคิดการพัฒนาที่องค์กรยึดมั่นและดำเนินการอย่างต่อเนื่องในระยะยาว 6. มองสู่อนาคต: ก้าวเดินอย่างมั่นคง เพื่อความก้าวหน้าอย่างยั่งยืน PGM ระบุว่า ช่วงปี 2026–2028 ถือเป็นระยะสำคัญที่บริษัทจะก้าวจาก การพัฒนาอย่างมั่นคง ไปสู่ ความเป็นองค์กรที่มีระบบและโครงสร้างสมบูรณ์ โดย PGM จะยึดมั่นในหลักการพัฒนาอย่าง ถูกต้องตามกฎหมาย โปร่งใส และมั่นคง พร้อมเติบโตร่วมกับพนักงาน พันธมิตรทางธุรกิจ และตลาดอย่างยั่งยืน PGM เชื่อมั่นว่า ก้าวอย่างมั่นคง จึงจะไปได้ไกล และมีเพียงแนวคิดการพัฒนาในระยะยาวเท่านั้น ที่สามารถสร้างคุณค่าที่แท้จริงได้   Contact: Daniel Thomas Email: pinnacleglobalmedia@gmail.com Website: www.pgmpy.com

-->

On:

With Long-Term Vision as its Core, PGM Embarks on a New Phase of High-Quality and Regionalized Development Recently, PGM officially released its 2026 development strategy and 2027-2028 mid-to-long-term development plan. Against the backdrop of a deepening global digital economy and evolving organizational structures, PGM will adhere to the core development philosophy of "stability, compliance, and long-term vision," comprehensively promoting organizational upgrades, system improvements, and regionalized development to lay a solid foundation for sustained growth in the coming years. PGM stated that this plan is not aimed at short-term expansion, but rather at long-term sustainable development, striving to build a mature platform system with a clear structure, stable operation, and replicability. I. 2026 Development Strategy: Strengthening the Foundation and Improving Quality 2026 will be considered a "critical year for strengthening the foundation" for PGM's development. The company will steadily advance around the following four strategic priorities: (I) Upgrading the Organizational System and Enhancing Management Capabilities PGM will continue to optimize its organizational structure and job division, improve promotion channels and management training systems, and focus on enhancing the comprehensive capabilities of middle and senior management personnel to create a more stable and sustainable team structure. (II) Comprehensively Strengthening Compliance and Risk Control Systems In terms of compliant operations, PGM will further enhance financial transparency, internal audit mechanisms, and system risk control capabilities, continuously strengthen data security and account management, and clarify and consolidate its market positioning of "formal positions, compliant operations, and long-term development." (III) Upgrading System and Technology Capabilities PGM plans to complete several system upgrades in 2026, including automated operational processes, optimized data statistics and performance settlement, providing a stable and efficient technical foundation for subsequent large-scale and cross-regional development. (iv) Brand building and positive market communication By unifying external information messaging and strengthening communication through mainstream media and social media platforms, PGM will further enhance its brand credibility and establish a "stable, professional, and trustworthy" corporate image. II. 2027-2028 Mid-to-Long-Term Plan: Deepening Development in Southeast Asia, Promoting Scale and Regionalization in Parallel After consolidating its system in 2026, PGM will officially enter a phase of accelerated scale and regionalization development centered on Southeast Asia in 2027-2028. The company will focus on the Southeast Asian market, particularly Thailand and Myanmar, steadily advancing regional expansion based on a mature operating model. 2027: Steady Scale Development Continue to expand team size in mature markets Cultivate more local leaders with independent management and replication capabilities Improve overall operational efficiency, personnel efficiency, and team stability 2028: Promoting Regionalization and Collaborative Development Gradually promote regional replication based on a mature operating model Build cross-regional management and collaboration mechanisms Create a multi-regional operating system with long-term viability PGM stated that regionalization development will be based on the premise of "steady progress and controllable risks," ensuring that each step of expansion is built upon a mature system. III. Accelerating Localization in Thailand: The Advertising and Recruitment System is Being Implemented at an Accelerated Pace With the increasing number of partnerships with local Thai brands, the platform's needs for advertising integration and business coordination are becoming increasingly clear. Based on this trend, PGM is steadily advancing its plan to establish an advertising and recruitment department in its Thailand branch, prioritizing initial setup in a Bangkok office building. Currently, the relevant arrangements are in the preparatory stage, including: office environment planning, staffing assessment, and optimization of the integration of advertising business processes with the platform system. If the overall progress is smooth, it is expected that the advertising and recruitment department will be ready for onboarding and trial operation within approximately one month, enabling more efficient integration with local Thai brands and partner resources. The company will steadily refine subsequent plans based on actual progress and make preliminary preparations for the future construction and occupancy of PGM's Thailand branch's independent office building. PGM consistently adheres to the development principles of "planning first, then implementation, long-term focus, and stability," ensuring that every step of its strategic deployment has sustainable value. IV. A People-Centric Long-Term Development Philosophy PGM firmly believes that the long-term growth of its employees is the company's most important competitive advantage. Over the next three years, the company will continue to invest resources in management talent development, the establishment of long-term incentive mechanisms, and the design of diversified revenue structures to provide employees with clearer and more predictable career development paths, achieving a virtuous cycle of personal growth and platform development. V. Fulfilling Social Responsibility: Giving Back to Society Through Long-Term Philanthropy While steadily advancing its corporate development, PGM has always prioritized long-term investment in corporate social responsibility. Over the next three years, PGM will integrate philanthropic and charitable activities into its long-term development system, giving back to society through sustainable and practical means. Last month, PGM responded proactively to the floods in Songkhla, Thailand, and organized a team to provide assistance to the affected people. Key Areas of Philanthropic Action Community Care: Providing regular assistance and donations of essential goods to grassroots communities. Educational Support: Focusing on learning opportunities and growth environments for youth and vulnerable groups. Employee Philanthropic Participation: Encouraging employees and teams to participate in philanthropic activities, fostering a positive corporate culture. PGM believes that a truly sustainable company should not only create economic value but also continuously create social value. PGM continuously engages in community service initiatives, actively fulfilling its corporate social responsibility. It focuses on educational development and supports the growth of young people through concrete actions. Employee participation in public welfare projects has become an important part of PGM's corporate culture. Public welfare is not a one-off act, but a long-term development philosophy that PGM adheres to. VI. Looking to the Future: Steady Progress for Sustainable Development PGM stated that 2026–2028 is a crucial period for the company, marking its transition from "steady development" to "system maturity." PGM will adhere to the principles of compliance, transparency, and steady growth, growing together with its employees, partners, and the market. PGM believes: Only by moving steadily can we go far; only through long-termism can we create true value. Contact: Daniel Thomas Email: pinnacleglobalmedia@gmail.com Website: www.pgmpy.com

-->

On:

New York, NY – December 26, 2025 – (SeaPRwire) – Taxinexo, a U.S.-based autonomous vehicle operator, has entered a new phase of large-scale commercial deployment after nearly five years of continuous operation in the United States. Leveraging its mature Level 4 autonomous driving technology and proven operational capabilities, the company has expanded multi-scenario services across several U.S. states, positioning itself as a representative case of how federal and state policy coordination is accelerating the commercialization of autonomous driving in the U.S. smart mobility sector. Since its inception, Taxinexo’s growth trajectory has been deeply intertwined with the US autonomous driving industry’s policy support system. The US federal government, through national strategic documents such as the Comprehensive Autonomous Vehicle Initiative, has established a development orientation of “safety first, encouraging innovation,” providing companies with a flexible regulatory environment—including simplified administrative exemption procedures for autonomous vehicles, allowing steering wheel-less and pedal-less vehicles that meet technical standards to be tested and operated on public roads, significantly lowering the policy threshold for companies to iterate their technology. Meanwhile, the Inflation Reduction Act’s tax credit of up to $7,500 per vehicle for Level 3 and above autonomous driving vehicles further assisted Taxinexo in completing its R&D investment and fleet expansion, enabling it to achieve large-scale commercial operation in multiple states across the US. This has allowed it to accumulate millions of kilometers of real-world road operation data and build an operational network covering diverse scenarios such as urban main roads, business parks, and commuter shuttles. In an interview with this newspaper, Taxinexo’s Global Marketing Head stated, “The policy support in the US over the past five years has provided us with an excellent development platform. From technology R&D to commercialization, the flexible regulatory environment and precise policy support have allowed us to accumulate core capabilities to handle complex scenarios. In the future, we will continue to leverage local policy advantages, deepen our diversified scenario operation layout, and help promote the US autonomous driving industry towards a more efficient and safer stage.” Data shows that the US autonomous driving industry is rapidly expanding, with leading companies continuously increasing their fleet sizes and weekly order volume exceeding hundreds of thousands, indicating a broad commercial prospect for the industry. Taxinexo reportedly plans to further expand its service coverage in the United States based on its existing operations, focusing on high-frequency travel scenarios such as airport shuttles and intercity commuting, and will continue to increase investment in technology research and development to promote the iterative upgrade of its autonomous driving system. In the future, its large-scale operational experience may provide a replicable practice model for the intelligent transportation upgrades of more cities in the United States. Social Links Telegram: https://t.me/taxinexo X: https://x.com/taxinexo Facebook: https://www.facebook.com/profile.php?id=61585301312596 Instagram: https://www.instagram.com/taxinexo LinkedIn: https://www.linkedin.com/company/taxinexo/ YouTube: https://www.youtube.com/@taxinexo Media contact Brand: Taxinexo Contact: Media team Email: support@taxinexo.com Website: https://www.taxinexo.com

-->

On:

The King of the Monsters Becomes a Cinematic Welcome and Farewell, Showcasing Japanese Entertainment to Millions of International Travelers at Japan’s Global Gateway Singapore – December 23, 2025 – (SeaPRwire) – The HANEDA GODZILLA GLOBAL PROJECT officially launched a mega-scale initiative to broadcast Japanese entertainment to the world from Haneda Airport, through the collaboration of three companies: Toho Co., Ltd., Japan Airport Terminal Co., Ltd., and Tokyo International Airport Terminal Corporation. Under the theme “Godzilla welcomes all visitors to Japan and sees them off as they depart,” a colossal Godzilla statue, approximately 40 meters long and 9 meters tall, has been revealed inside Japan’s international gateway at Haneda Airport Terminal 3. Modeled after the original Godzilla, the monument surpasses the size of existing indoor installations and is designed to be viewed from multiple angles throughout Terminal 3. Additional installations in the area include Godzilla: The Great Monster Advance Picture Scroll in the arrival lobby and a standing statue from Godzilla Minus One that will be installed on December 3, further expanding the presence of the popular monster across arrivals and departures. To commemorate the completion of the world’s largest indoor Godzilla monument, a special announcement event was held at Haneda Airport, featuring remarks from notable guests. This consisted of Keiji Ota, Senior Managing Executive Officer and Chief Godzilla Officer (CGO) of Toho Co., Ltd.; Masatoshi Akahori, President and Representative Director of Tokyo International Air Terminal Corporation; and special guest actress Riko Fukumoto, ambassador for the “Godzilla The Ride” attraction at Seibuen Amusement Park. All of the guest speakers reflected on the cultural significance of the six-year project and Godzilla’s role as a global symbol of Japanese entertainment. As travel ramps up for the new year, the HANEDA GODZILLA GLOBAL PROJECT is set to leave a lasting impression on millions of international travelers passing through Terminal 3 with an encounter with one of Japan’s most iconic cultural symbols. The completion announcement event was held on Friday, December 19, with public installations opening in conjunction with year-end and New Year travel, and additional displays debuting beginning December 23. The unveiling was held at Haneda Airport Terminal 3 in Tokyo, Japan spanning both the departure and arrival lobbies at Japan’s primary international gateway. About TOHO Co., Ltd. TOHO Co., Ltd. is a leading Japanese entertainment company founded in 1932.  Its four main business pillars are the cinema business, which includes production, distribution and exhibition; the theatrical business, which includes production and exhibition; the anime business, which has been expanding globally in recent years; and the real estate business, which focuses on development in urban areas. TOHO’s worldwide acclaimed works include theatrical films such as the “Godzilla” series and “Seven Samurai” directed by Akira Kurosawa, and TV anime series such as “My Hero Academia” and “Jujutsu Kaisen”. These anime series are produced and distributed through the TOHO animation label, and are delivered to a wide range of audiences around the world. Media Contact TOHO Entertainment Asia hello@tohoea.com.sg

-->

On:

New York, NY – December 23, 2025 – (SeaPRwire) – Holiverse, a biotech platform, has begun active development of a decentralized AI device designed to operate entirely offline without cloud dependency. The device will embed private artificial intelligence directly on hardware, eliminating the need to transmit personal data to external servers. According to the company, this approach addresses growing concerns about data sovereignty, privacy erosion and the concentration of AI processing power in centralized platforms. “We have conflated intelligence with centralization,” said Lado Okhotnikov, founder of Holiverse. “We built these vast, brilliant minds and asked them to solve our problems. But in doing so, we outsourced our sovereignty.” The Holiverse decentralized AI initiative targets three key capabilities: On-device processing: All data remains in a closed loop on the user’s hardware Offline functionality: Intelligence operates without internet connectivity Hyper-personalization: Models tuned to individual biological and behavioral data “This is undoubtedly a complex and resource-intensive process, and we are engaging some of the leading AI specialists,” Okhotnikov added. “This technology has the potential to significantly reduce the risks associated with AI and make interaction with it truly personal.” Holiverse expects to present initial developments publicly in the coming months. About Holiverse Holiverse is a biotech platform that integrates human biology and advanced technology. Founded by Lado Okhotnikov, the company creates holistic health solutions through personalized, data-driven approaches. Learn more at holiverse.ai. Social Links X: https://x.com/Holiverse Telegram: https://t.me/holiverse_ENG Media Contact Brand: Holiverse Contact: Media team Email: mailbox@holiverse.ai Website: https://holiverse.ai

-->

On:

Seoul, Korea – December 23, 2025 – (SeaPRwire) – HTM Korea, a Korean fire-safety technology company, announced the global expansion of its innovative automatic fire-suppression product line, CERA+, designed to prevent electrical fires in outlets and distribution boards. The company has rapidly grown within the domestic market through public procurement channels, supplying products to government agencies, educational institutions, and major industrial clients. CERA+ is a compact fire-suppression patch that activates automatically when an electrical hotspot occurs. Containing a certified clean-agent extinguishing compound, the patch bursts at a specific temperature and releases the agent to suppress flames at the earliest stage. The product has received official KFI (Korea Fire Institute) type approval, along with reliability tests such as temperature, humidity, and durability evaluations. HTM Korea currently offers outlet-type patches and distribution-board models in 20L, 40L, and 80L capacities. The company is accelerating its entry into Southeast Asia, the Middle East, and the United States, supported by growing demand from data centers, residential complexes, and industrial facilities. “As electrical fire risks continue to rise worldwide, we aim to provide simple but highly effective protection that any facility can adopt easily,” said a company representative. “We will continue expanding our product line and strengthening global partnerships.” Media contact Company: HTM Korea Co., Ltd. Contact: Su Hyeon Oh Phone: +82-10-3504-2913 Email: cera@cera.krWebsite: https://www.cera.kr

-->

On:

Seoul, Korea – December 23, 2025 – (SeaPRwire) – The Third Market Co., Ltd. has opened Korea’s first Experiential Refurbished Electronics Showroom, a space where customers can directly test, compare, and verify refurbished electronics with full transparency. The showroom was created to solve long-standing consumer concerns around inconsistent quality and unclear product history in the refurb market. The Third Market manages the entire process in-house, including inspection, grading, labeling, and warranty issuance. Visitors can observe real-time inspection, review visualized product reports, and experience devices firsthand—shifting refurbished products from “low-cost alternatives” to “value-verified choices.” The showroom integrates an inspection center, exhibition zone, and logistics area, enabling seamless processing from intake to purchase. With its internal branding and design team, Third Market provides standardized labels, branded packaging, and expert consultations to enhance consumer trust. A dedicated Small Business Pop-Up Zone also supports local merchants by offering a new retail channel for overstock and returned goods, contributing to a healthier refurb ecosystem. “Our goal is to establish a new standard of trust in refurbished electronics,” said CEO Sang-ho Yoo. “Customers should be able to see exactly how products are evaluated and feel confident in their value.” The Third Market plans to expand additional hubs, enhance automated inspection technology, and strengthen global partnerships as it shapes the future of the refurbished electronics market. Media contact Brand: The Third Market Contact: Sang-ho Yoo Phone: +821041143582 Email: biz@ttm.imWebsite: https://shop.ttm.im

-->

On:

Singapore – December 22, 2025 – (SeaPRwire) – Asia Pricing Professionals (APP), the leading pricing and commercial excellence community in Asia-Pacific, today announced a major expansion of its professional development, certification, and community platform for 2026. The expanded portfolio positions APP as the region’s most comprehensive ecosystem for pricing, value management, and revenue excellence. Central to the 2026 expansion is a strategic partnership with the Professional Pricing Society (PPS), connecting global best practices with regional execution to support individuals, teams, and organizations as pricing evolves into a strategic, AI-enabled business capability. Comprehensive Pricing Training & Global Certifications From 2026, APP members will gain access to 100+ on-demand pricing courses through its collaboration with PPS, covering the full pricing and monetization lifecycle — from foundational principles to advanced real-world application. The curriculum spans: Pricing strategy and value creation Pricing analytics and data-driven decision-making Execution, governance, and price realization Negotiation and deal pricing SaaS and XaaS monetization models AI-enabled pricing and advanced analytics Organizational design and change management In addition, APP will offer globally recognized certifications, including the Certified Pricing Professional (CPP®) designation — the only worldwide credential synthesizing the art and science of pricing — and a new AI Pricing Certification, designed to help professionals apply artificial intelligence responsibly and effectively in pricing, forecasting, and commercial decision-making. Two Flagship APP Conferences in Singapore (2026) As part of its expanded offering, APP will host two one-day flagship conferences in Singapore in 2026, bringing together senior pricing, commercial, and revenue leaders from across Asia-Pacific. APP Conference 1 5 March 2026 | Singapore Theme: Smart Value: AI and the Future of Pricing & Revenue Growth The conference will explore how AI, analytics, and advanced pricing capabilities are transforming value creation, pricing decisions, and sustainable revenue growth. Key topics include AI-driven pricing, predictive analytics, price corridors, deal pricing, execution excellence, and ethics and governance in AI-enabled pricing. APP Conference 2 15 October 2026 | Singapore Theme: Total Revenue Excellence: Integrating Pricing, Profitability & Commercial Performance This event will focus on breaking organizational silos between Pricing, Sales, Finance, Revenue Management, and Commercial Operations to drive end-to-end revenue and profit performance. Key topics include deal desk design, discount discipline, KPI alignment, commercial operating models, and scaling revenue excellence across regions. Face-to-Face Training & Regional Networking Immediately following each conference, APP will deliver in-person, instructor-led training programs in Singapore on 6 March and 16 October 2026. These hands-on sessions focus on applied execution and advanced case work, and both count toward CPP® certification credits. In the second half of 2026, APP will also launch its “Five Big Cities” Networking Tour, with events planned in: Bangkok Jakarta Manila Shanghai Singapore Each event will feature curated networking, practitioner roundtables, and thought leadership discussions, strengthening APP’s role as a regional connector between local markets and global best practices. An Integrated Pricing Ecosystem for Asia-Pacific Together, APP’s training, certifications, conferences, live programs, and regional networking form a single integrated ecosystem designed to: Build pricing and commercial capability at scale Bridge theory with real-world execution Support career progression and organizational maturity Advance ethical, data-driven, and AI-enabled pricing across Asia-Pacific About Asia Pricing Professionals (APP) Founded in 2010, Asia Pricing Professionals is a not-for-profit community dedicated to advancing pricing, value management, and commercial excellence across Asia-Pacific. APP connects practitioners, leaders, and organizations through education, certification, events, and peer collaboration. Social Links LinkedIn: https://www.linkedin.com/groups/3813123/ Instagram: https://www.instagram.com/asiapricingprofessionals Media contact Brand: Asia Pricing Professionals Contact: Media team Email: deepaksood@asiapricingprofessionals.org Website: https://asiapricingprofessionals.org

-->

On:

SHENZHEN, Dec 15, 2025 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for an independent listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of the Company dated 22 April 2025 for details), has obtained the relevant licensing rights to the innovative oral JAK1 inhibitor povorcitinib (proposed English generic name: Povorcitinib Phosphate Tablets) (“povorcitinib” or the “Product”), which has been included in the list of Breakthrough Therapeutic Drugs by the Center for Drug Evaluation of the National Medical Products Administration of the People’s Republic of China (“NMPA”), with a proposed indication for adult patients with non-segmental vitiligo. This certification has the potential to accelerate the development and review process of the Product. Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for non-segmental vitiligo, moderate to severe hidradenitis suppurativa (HS) and prurigo nodularis in several countries outside China. A Phase 2 clinical trial for the treatment of asthma is also ongoing. In March 2023, Incyte announced that povorcitinib met the primary endpoint in a global multi-center Phase 2b clinical trial for non-segmental vitiligo. Results showed that after 24 weeks of treatment, compared with vehicle, total body repigmentation of patients treated with povorcitinib once daily was significantly improved. Furthermore, according to the extended Phase 2b trial, longer-term use of povorcitinib demonstrated further improvement in total body and facial repigmentation with a favorable tolerability profile[1].  In August 2025, Dermavon received the drug clinical trial approval notice issued by NMPA to conduct clinical trials of povorcitinib for the treatment of non-segmental vitiligo and other indications. Dermavon has initiated the clinical development of the Product in China and may consider further initiating clinical development of povorcitinib in China for the treatment of skin-related diseases such as HS and prurigo nodularis in the future. Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[2]. Currently, therapeutic options for vitiligo are limited, and the condition is difficult to treat, especially for patients with moderate to severe extensive vitiligo. If approved in China, povorcitinib could provide a differentiated treatment option for patients with non-segmental vitiligo. The Product’s inclusion in the list of Breakthrough Therapeutic Drugs is expected to accelerate its development and review process in mainland China. If approved for marketing in China, the Product has the potential to synergize with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream) and the innovative drug currently under New Drug Application (NDA) review ruxolitinib phosphate cream, helping the product to quickly realize its clinical and commercial value and benefit more patients with skin diseases. Furthermore, if approved, the Product, together with topical ruxolitinib phosphate cream, will provide vitiligo patients with differentiated and comprehensive treatment options. The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement (the “License Agreement”) for povorcitinib on 31 March 2024 with Incyte, obtaining an exclusive license to research, develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights of povorcitinib in the Territory other than Mainland China to the Group (excluding Dermavon and its subsidiaries). About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.  Reference: 1. Results from a global multi-center Phase 2b clinical trial of the product for non-segmental vitiligo indication can be found on the Incyte official website: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-data-phase-2b-study-evaluating-povorcitinib 2. Datas are from the China Insights Consultancy (CIC) report CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/

-->

On:

Bangkok, Thailand | 8–12 December 2025 — ANGEL participated in the IWA Water and Development Congress & Exhibition (WDCE), showcasing solutions for medium and large-scale water treatment projects and bottleless RO water dispensers for public and office use. Zhao Kai, Vice President of ANGEL Group, attended the opening and delivered remarks, highlighting ANGEL’s innovation and its commitment to international collaboration for sustainable development. The congress, co-hosted by IWA and the Asian Institute of Technology under the theme “Water, sanitation, and innovation – pathways to progress and a resilient future”, brought together around 2,000 participants from over 90 countries and regions. Reshaping the Landscape of Intelligent Water-Quality Monitoring  On 9 December, Lei Jing, a technical expert from ANGEL’s Central Research Institute, presented ANGEL’s patented AIMS precision ion-sensing technology at a WDCE thematic forum, drawing strong interest from global water-sector experts. As demand grows for accurate control of mineral-ion concentrations, AIMS addresses long-standing limits of conventional ion-detection devices. With an innovative electrode design, it reduces electrode loss, improves accuracy, and avoids frequent calibration. It upgrades monitoring from manual estimation and periodic sampling to real-time feedback and intelligent control, combining high-precision measurement with data visualisation. AIMS has won a Gold Medal at the Geneva International Exhibition of Inventions. Optimised for cost and size, AIMS can be integrated into a wide range of water-treatment equipment and remain stable over long-term use without routine calibration. Beyond household water applications, it shows promise across research, biomedicine, environmental protection, and industrial and agricultural sectors—potentially lowering carbon footprints and supporting water recycling for more sustainable water management. A New Paradigm for Efficient, Long-Lasting Water Disinfection  On 11 December at the IWA WDCE, Chen Qingyan, technical expert at ANGEL’s Central Research Institute, presented ANGEL’s new water-disinfection technology and its purification applications in the session on emerging contaminants and disinfection. Addressing bacterial contamination in long-used purifiers, ANGEL spent seven years developing APCM “space-grade” antimicrobial technology, which physically attracts bacteria and ruptures cell membranes, achieving up to a 99.99% removal rate against ESKAPE pathogens. Conference experts viewed it as a promising new approach to drinking-water safety, and ANGEL drew strong attention for its innovative, scenario-based solutions and its commitment to advancing efficient, intelligent, and environmentally sustainable water treatment.

-->

On:

กรุงเทพฯ ประเทศไทย | 8–12 ธันวาคม 2025 — ANGEL เข้าร่วมงาน IWA Water and Development Congress & Exhibition (WDCE) โดยนำเสนอโซลูชันสำหรับโครงการบำบัดน้ำขนาดกลางและขนาดใหญ่ รวมถึงตู้กดน้ำ RO แบบไม่ใช้ขวดสำหรับการใช้งานในพื้นที่สาธารณะและสำนักงาน จ้าว ไค รองประธานกลุ่มบริษัท ANGEL เข้าร่วมพิธีเปิดและกล่าวสุนทรพจน์ เน้นย้ำถึงนวัตกรรมของ ANGEL และความมุ่งมั่นในการร่วมมือระดับนานาชาติเพื่อการพัฒนาที่ยั่งยืน การประชุมซึ่งจัดร่วมกันโดย IWA และสถาบันเทคโนโลยีแห่งเอเชีย ภายใต้หัวข้อ “น้ำ สุขาภิบาล และนวัตกรรม – เส้นทางสู่ความก้าวหน้าและอนาคตที่ยืดหยุ่น” ได้รวบรวมผู้เข้าร่วมประมาณ 2,000 คนจากกว่า 90 ประเทศและภูมิภาค เมื่อวันที่ 9 ธันวาคม เหลย จิ้ง ผู้เชี่ยวชาญด้านเทคนิคจากสถาบันวิจัยกลางของ ANGEL ได้นำเสนอเทคโนโลยีตรวจวัดไอออนความแม่นยำสูง AIMS ที่ได้รับสิทธิบัตรของ ANGEL ในเวทีเสวนาเฉพาะด้านของ WDCE ซึ่งได้รับความสนใจอย่างมากจากผู้เชี่ยวชาญด้านน้ำจากทั่วโลก ท่ามกลางความต้องการที่เพิ่มขึ้นในการควบคุมความเข้มข้นของไอออนแร่ธาตุอย่างแม่นยำ AIMS เข้ามาแก้ไขข้อจำกัดที่มีมานานของอุปกรณ์ตรวจจับไอออนแบบดั้งเดิม ด้วยการออกแบบอิเล็กโทรดที่เป็นนวัตกรรม ช่วยลดการสึกหรอของอิเล็กโทรด เพิ่มความแม่นยำ และหลีกเลี่ยงความจำเป็นในการปรับเทียบบ่อยครั้ง เทคโนโลยีนี้ยกระดับการตรวจวัดจากการประเมินด้วยมือและการเก็บตัวอย่างเป็นระยะ ไปสู่การตอบสนองแบบเรียลไทม์และการควบคุมอัจฉริยะ ผสานการวัดที่มีความแม่นยำสูงเข้ากับการแสดงผลข้อมูลอย่างเป็นภาพ AIMS ได้รับรางวัลเหรียญทองจากงาน Geneva International Exhibition of Inventions AIMS ได้รับการปรับให้เหมาะสมทั้งด้านต้นทุนและขนาด สามารถผสานรวมเข้ากับอุปกรณ์บำบัดน้ำหลากหลายประเภท และคงความเสถียรในการใช้งานระยะยาวโดยไม่ต้องปรับเทียบเป็นประจำ นอกเหนือจากการใช้งานในครัวเรือนแล้ว เทคโนโลยีนี้ยังมีศักยภาพในงานวิจัย ชีวการแพทย์ การคุ้มครองสิ่งแวดล้อม รวมถึงภาคอุตสาหกรรมและการเกษตร ซึ่งอาจช่วยลดคาร์บอนฟุตพริ้นต์และสนับสนุนการรีไซเคิลน้ำ เพื่อการจัดการทรัพยากรน้ำที่ยั่งยืนยิ่งขึ้น กระบวนทัศน์ใหม่ของการฆ่าเชื้อน้ำที่มีประสิทธิภาพและยาวนาน เมื่อวันที่ 11 ธันวาคม ในงาน IWA WDCE เฉิน ชิงเหยียน ผู้เชี่ยวชาญด้านเทคนิคจากสถาบันวิจัยกลางของ ANGEL ได้นำเสนอเทคโนโลยีการฆ่าเชื้อน้ำรูปแบบใหม่ของ ANGEL และการประยุกต์ใช้ในการทำให้น้ำบริสุทธิ์ ภายในหัวข้อการประชุมว่าด้วยสารปนเปื้อนเกิดใหม่และการฆ่าเชื้อ เพื่อตอบโจทย์ปัญหาการปนเปื้อนของแบคทีเรียในเครื่องกรองน้ำที่ใช้งานมาเป็นเวลานาน ANGEL ใช้เวลากว่าเจ็ดปีในการพัฒนาเทคโนโลยีต้านจุลชีพ APCM ระดับ “อวกาศ” ซึ่งอาศัยการดึงดูดแบคทีเรียทางกายภาพและทำลายเยื่อหุ้มเซลล์ ส่งผลให้สามารถกำจัดเชื้อก่อโรคกลุ่ม ESKAPE ได้สูงถึง 99.99% ผู้เชี่ยวชาญในการประชุมมองว่าเทคโนโลยีนี้เป็นแนวทางใหม่ที่มีศักยภาพในการยกระดับความปลอดภัยของน้ำดื่ม และ ANGEL ได้รับความสนใจอย่างมากจากโซลูชันเชิงนวัตกรรมที่ออกแบบตามสถานการณ์จริง รวมถึงความมุ่งมั่นในการผลักดันการบำบัดน้ำที่มีประสิทธิภาพ อัจฉริยะ และเป็นมิตรต่อสิ่งแวดล้อม

On:

SHENZHEN, Dec 11, 2025 – (ACN Newswire) – China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) (“Y-3 for Injection” or the “Product”) has been accepted by National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a brain cytoprotectant indicated for the treatment of acute ischemic stroke. With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important targets PSD95-nNOS and MPO, in the pathological processes of stroke, Y-3 for Injection acts on multiple key pathological processes of the ischemic cascade in ischemic stroke. Through multi-target, highly selective synergy, it is more conducive to exerting brain cytoprotective effects. The Product has an excellent therapeutic effect on ischemic stroke and the potential to prevent post-stroke depression and anxiety symptoms. Y-3 for Injection demonstrates excellent clinical data with excellent efficacy and a favorable safety profile. The results of Phase II clinical trial of the Product in China indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (40mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group, with a rate difference of 16%. The Phase III clinical trial of the Product in China was conducted by Beijing Tiantan Hospital, Capital Medical University as the leading site. It has enrolled nearly 1,000 patients with acute ischemic stroke within 48 hours of onset across approximately 40 research centers nationwide, aiming to evaluate the efficacy and safety of Y-3 for Injection in treating patients with acute ischemic stroke within 48 hours of onset. The Phase III clinical study met the primary efficacy endpoint, with patients achieving significant clinical benefits and an overall favorable safety profile. The key study results are planned to be presented at international academic conferences, and the full study will be published in international academic journals. The Central Nervous System (CNS) is one of the core advantageous fields of CMS, where a deeply integrated layout has been progressively established. The product portfolio has solidified the market foundation, including the marketed innovative drug VALTOCO (Diazepam Nasal Spray), the original brand drug Deanxit (Flupentixol and Melitracen Tablets), and the improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets), which is currently under NDA review. The addition of Y-3 for Injection will further strengthen the product portfolio, generating highly efficient synergies in terms of expert networks and market resources. It is expected that if approved for marketing, Y-3 for Injection will bring a new generation of brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects to Chinese patients with ischemic stroke. Leveraging the successful commercialization experience and compliant and efficient operation system, the Group will accelerate the accessibility of innovative therapies to benefit more patients. More Information about Y-3 for Injection The pathological processes of acute ischemic stroke are highly complex and interconnected. There is an urgent clinical need for multi-target, multi-mechanism coordinated interventions to achieve more effective regulation of the complex ischemic cascade, thereby improving treatment outcomes and enhancing patients’ quality of life. Y-3 for Injection is able to uncouple PSD95-nNOS, inhibit MPO activity, and enhance the activity of α2-GABAA receptor (a subtype of GABAA receptor with antidepressant and anxiolytic effects). With this multi-target, highly selective synergistic mechanism, it is expected to achieve a technological breakthrough in the simultaneous intervention of “stroke treatment and prevention of post-stroke depression and anxiety”, making Y-3 for Injection a promising novel brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects. The results of Phase II clinical trial of Y-3 for Injection for the treatment of acute ischemic stroke were presented as an oral poster at the 10th European Stroke Organisation Conference in 2024 (ESOC 2024). It indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (20mg, 40mg, 60mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group (20mg: 67.8% vs 60.7%, 40mg: 76.7% vs 60.7%, 60mg: 70.0% vs 60.7%). Moreover, the Product showed comparable safety to placebo in acute ischemic stroke patients, exhibiting good tolerability. On 24 August 2023, the Group through its wholly-owned subsidiary entered into a Collaboration Agreement (the “Agreement”) with Neurodawn Pharmaceutical Co., Ltd. (“NeuroDawn”), a clinical needs-oriented pharmaceutical company driven by innovation and R&D. In accordance with the Agreement, the Group obtains an exclusive promotion right in mainland China, the Hong Kong Special Administrative Region, and the Macau Special Administrative Region. The term of the Agreement is permanent. About Stroke According to the Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) issued by the National Health Commission, approximately 3.94 million new stroke cases occur in China each year, accounting for one-third of the global new cases[1]. Among these, ischemic stroke accounts for about 72%, with over 2.8 million new cases annually; the number of existing stroke patients in China has exceeded 28 million[1]. Data from China’s cause-of-death monitoring in 2021 shows that stroke-related deaths accounted for 23% of the national total deaths[1]. Over the past three decades, the disease burden of stroke-related disabilities in China has continued to increase[1]. Coupled with factors such as the accelerating aging of the population, the pressure of stroke prevention and control will further intensify in the future, posing enormous challenges to patients’ families and society[1]. In addition, post-stroke depression and anxiety are common complications of stroke, with incidence rates of approximately 30% and 25% respectively[2]. They can hinder the recovery of patients’ neurological functions, even increase the risk of death, and severely affect patients’ prognosis. Y-3 for Injection holds significant potential value for the long-term neurological function improvement and overall prognosis of a vast number of stroke patients, indicating broad market prospects. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference 1. National Health Commission of the People’s Republic of China. Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) [J]. Chinese Journal of Magnetic Resonance Imaging, 2025, 16(1): 1-8. DOI: 10.12015/issn.1674-8034.2025.01.001. 2. Chen Xinyu, Lyu Xiaohan, Li Ruina, et al. Post-Stroke Anxiety [J]. International Journal of Cerebrovascular Disease, 2022, 30(2): 129-133. DOI: 10.3760/cma.j.issn.1673-4165.2022.02.010. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/

-->

On:

New York, NY – December 08, 2025 – (SeaPRwire) – CryptoFeeDiscount, a premier cryptocurrency data aggregation platform, today announced the official launch of its advanced Crypto Trading Fee Savings Calculator. Designed for quant institutions and high-volume traders, this new data-driven engine reveals hidden transaction costs and identifies optimized execution strategies to reduce trading fees by up to 30%. As crypto market volatility increases in late 2025, transaction costs have become a silent profit killer for active traders. A typical futures trader generating $5 to $10 million in monthly volume can lose upwards of $400 to $600 per month in unnecessary maker/taker fees without optimized account structuring. CryptoFeeDiscount addresses this issue by providing a transparent, data-driven interface that allows users to: Compare Real-Time Rates: Instantly visualize the cost difference between top-tier derivatives exchanges like Bitget and Binance. Unlock VIP Fee Discounts for Free: Access exclusive, institutional-grade fee reductions usually reserved for VIP 1-3 levels, bypassing standard trading volume requirements. Verify Promo Codes: Utilize the platform’s database of verified Referral Codes and Promo Codes to ensure maximum sign-up bonuses and lifetime fee rebates. Discover Niche Opportunities: Filter exchanges by specific criteria, such as “Privacy-First” features for secure trading or high-leverage trading options. “Most retail traders obsess over entry and exit prices but completely ignore the frictional cost of trading,” said James Anderson, Lead Analyst at CryptoFeeDiscount. “Our data shows that by simply switching execution venues or applying a verified discount code on platforms like Bitget, a scalper can increase their net profitability by over 15% annually. We built this calculator to make that math visible and actionable.” The platform has already verified and indexed active promo codes for major platforms, ensuring users have access to the lowest possible rates currently available on the market, with savings reaching up to 30% on select crypto exchanges. ABOUT CRYPTOFEEDISCOUNT CryptoFeeDiscount is a leading financial technology website dedicated to transparency in cryptocurrency trading costs. Through its proprietary comparison engine and rigorous verification process, the platform helps traders find the best execution venues, referral codes, and sign-up bonuses. MEDIA CONTACT Brand: CryptoFeeDiscount   Contact: James Anderson Email: team@CryptoFeeDiscount.com Website: https://CryptoFeeDiscount.com

On:

SUMMIT, N.J. – December 05, 2025 – (SeaPRwire) – Leapfrog Acquisition Corporation (the “Company”) announced today the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units are expected to commence trading on December 5, 2025 on the Global Market tier of The Nasdaq Stock Market LLC under the symbol LFACU. The Company, which is led by Matthew R. Pollard, Abhay N. Pande and Kevin M. Murphy, is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Each unit sold in the offering consists of one Class A ordinary share (an “ordinary share”) and one half of one redeemable warrant with a strike price of $11.50 per ordinary share exercisable within 5 years of the Company completing an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and warrants are expected to be listed on the Global Market tier of The Nasdaq Stock Market LLC under the symbols “LFAC” and “LFACW,” respectively. BTIG, LLC is serving as the sole book-running manager of the offering. The underwriters have been granted a 45-day option to purchase up to an additional 1,875,000 units at the initial public offering price to cover over-allotments, if any. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (the “SEC”) on December 4, 2025. The offering was made only by means of a prospectus, copies of which, when available, may be obtained by contacting BTIG, LLC, 65 East 55 Street, New York, NY 10022, by emailing ProspectusDelivery@btig.com, or by visiting the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Leapfrog Acquisition Corp Leapfrog Acquisition Corp is a blank check company organized for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or engaging in any other similar business combination with one or more businesses or entities. The Company is led by Chief Executive Officer, Matthew R. Pollard, President and Chief Investment Officer, Abhay N. Pande and Chief Financial Officer, Kevin M. Murphy. The Company will prioritize businesses in the international energy supply chain and critical minerals sectors, including their related infrastructure in its search for attractive merger candidates. Forward-Looking Statements This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the anticipated use of the proceeds of the Company’s initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements, including those set forth in the risk factors section of the registration statement and prospectus for the Company’s initial public offering. Copies of these documents can be accessed through the SEC’s website at www.sec.gov. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law. Media Contact Company: Leapfrog Acquisition Corp Contact: Media Team Telephone: +1-201-379-4200 LinkedIn: https://www.linkedin.com/company/leapfrog-acquisition-corporation  Email In the US: abhay@leapfrogspac.com Email In Asia: matt@leapfrogspac.com kevin@leapfrogspac.com

-->

On:

Legiit Takes a Bold Step Forward with a Fresh Look and Expanded Offerings for Comprehensive Digital Marketing Myrtle Beach, SC – October 20, 2024 – (SeaPRwire) – Legiit, a leading digital marketplace for SEO and marketing services, has rebranded with a new logo and is setting the stage for the next chapter in its journey. With a focus on maintaining its strong foundation in SEO and backlink services, Legiit also plans to introduce new categories that will provide even more value to businesses seeking a one-stop solution for their marketing needs. Legiit remains committed to delivering exceptional link building services, a critical component in improving search engine rankings and driving online visibility. The platform offers a variety of link building packages designed to meet the needs of businesses at every stage of their digital marketing journey. Freelancers on Legiit specialize in providing high-quality backlinks, which are essential for boosting a website’s authority in search engine results. Offerings include foundation backlinks, Google and Amazon cloud backlinks, advanced link building services, and private blog network (PBN) services. Additionally, businesses can benefit from press releases, blog comment links, profile links, guest posting, and niche edit links to strengthen their online presence. These link building services ensure that Legiit clients have access to proven strategies to enhance their SEO efforts and maximize their digital marketing impact. Legiit’s dedication to enhancing local visibility for businesses is evident through its comprehensive local SEO services. For companies looking to dominate their local markets, Legiit provides access to thousands of freelance local SEO experts. These professionals offer targeted local SEO packages designed to improve Google Maps rankings and optimize Google Business Profiles. From boosting search engine visibility to driving more local traffic and generating leads, Legiit’s local SEO service is tailored to help businesses stand out in their communities. The platform’s experts offer strategies that include optimizing business listings and using the latest local SEO techniques to ensure that companies reach their target audiences effectively. Legiit’s rebranding marks more than just a visual transformation; it represents the company’s vision to continually evolve its offerings and meet the changing needs of businesses in the digital marketing landscape. The upcoming launch of new service categories will broaden Legiit’s capabilities, positioning it as an all-in-one solution for marketing strategies beyond SEO. These new categories will encompass other digital marketing channels, allowing businesses to leverage Legiit as their go-to resource for comprehensive growth strategies. As the company expands its focus, its mission remains clear—to provide businesses with effective tools and services that drive results. About Legiit Legiit is a dynamic digital marketplace connecting businesses with top freelance talent specializing in SEO, link building, local SEO, and a wide range of digital marketing services. With a commitment to delivering value through innovative strategies, Legiit aims to empower businesses to achieve their marketing goals. The platform offers tailored services that cater to both startups and established companies looking to enhance their online presence and grow their customer base. To explore Legiit’s offerings, visit Legiit. Media Contact Brand: Legiit Contact: Media team Email: help@legiit.com Website: https://legiit.com The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...